We examined human growth hormone's (hGH) effect on mitogenesis in cbltured human fibroblasts, and the role of local insulin-like growth factor I (IGF-I). With 0.5% human hypopituitary serum (HPS), hGH increased thymidine incorporation (TI) over serum-free medium dose responsively, with half-maximal effect at 10 ng/ml (0.5 nM) (hGH 127±8.8%; IGF-I 107±(1.7% [SEMI) (n = 10). Similarly, with 0.5% HPS, hGH and IGF-I increased cell replication by 172±8.2% and 169±25%, respectively (n = 4). Specific IGF-I monoclonal antibody (Sml.2) dose dependently blunted TI stimulated by 10 ng/ml hGH or IGF-I (at 1:1000, 38±6.5% and 30±14% reduction, respectively). Sml.2 also reduced cell replication by both 10 ng/ml hGH and IGF-I, respectively, to 32% and 42% of stimulated values. Dexamethasone (0.1 MiM) synergistically enhanced TI by both IGF-I and hGH. A 28-h time course for TI showed that hGH stimulated a similar peak to IGF-I, lagging in its effect by 4-10 h. We have provided further evidence that hGH stimulates growth of cultured human fibroblasts via local IGF-I production, consistent with IGF-I's paracrine-autocrine role.
Introduction
Although it is well recognised that human growth hormone (hGH)' plays a central role in growth, the exact mechanism of its mitogenic effect in human tissues remain unclear, with evidence for direct and indirect actions.
In 1957 Salmon and Daughaday postulated that the growth-promoting effects of growth hormone (GH) are mediated via secondary substances, now known as somatomedins or insulin-like growth factors (1, 2) . With the development of specific radioimmunoassays it became clear that insulin-like growth factor I (IGF-I) levels correlated well with different growth states in humans and with GH levels (3). IGF-I may also play an important role in the negative feedback mechanism for hGH (4, 5) . In vivo evidence for IGF-I's growth-promoting effect comes from infusion studies in hypophysectomised rats (6, 7) . A paracrine and autocnrne role for IGF-I is supported by the finding that it is produced by cultured human fibroblasts and acts locally on them (8) (9) (10) (11) (12) . Clemmons and co-workers have provided indirect evidence that hGH acts via this local IGF-I production in cultured human fibroblasts. With frequent replacement of medium after GH treatment, DNA synthesis was blunted, suggesting action via a local product, possibly somatomedin-C (IGF-I), addition of which maintained DNA synthesis (10) . However, a direct link between GH and IGF-I-mediated mitogenesis has not been established. Specific hGH binding sites have been demonstrated on cultured human fibroblasts so providing a potential site of action for hGH in this tissue (13) .
There is evidence for GH exerting its mitogenic effect directly on target tissues, such as rat tibial cartilage (14, 15) , erythroid precursor cells (16) , and cultured rabbit chondrocytes (17) . However, this does not exclude stimulation of local IGF-I production in these tissues. Nilsson et al. have recently demonstrated that GH injection in hypox rats stimulates local IGF-I synthesis in tibial growth cartilage ( 18) .
Workers have failed to show an effect of hGH alone on DNA synthesis in fibroblasts (Rosenfeld, R. G., R. L. Hintz, personal communication), but recently the role of serum competence factors in cell growth has been emphasized (10, 19) . These include platelet-derived growth factor, present in normal serum as well as in serum deficient in hGH and IGF-I from hypopituitary ("hypox") individuals (10) . We therefore chose to examine the effects of hGH in the presence of small amounts of human hypox serum, and a cell line known to elaborate IGF-I locally. Our aims were to examine for possible mitogenic effects of hGH in cultured human fibroblasts and to further investigate whether hGH acts on fibroblasts via local IGF-I production.
Methods

Cell culture
Human fibroblasts from three cell lines cultured from the pubic skin of normal adult males were used. The cells were grown to confluency in tissue culture bottles 
Results
Stimulation of[3H]TI
The stimulation of TI in the fibroblasts by hGH and IGF-I is shown in Fig. 1 To examine the possible role of local IGF-I production in the hGH-induced DNA synthesis, we examined the effect of concurrent addition ofa specific monoclonal Ab to IGF-I. The monoclonal Ab to IGF-I was added at a dilution of 1:1000 (n = 8) (Fig. 4) . The Ab reduced TI stimulated by IGF-I at 10 ng/ml (plus 0.5% HPS) by 30±14% (P < 0.01). Significantly, it also reduced TI stimulated by hGH at 10 ng/ml (plus 0.5% HPS) by 38±6% (P < 0.05). A monoclonal Ab to heart worm, prepared by a similar method, did not reduce TI stimulated by either IGF-I or hGH (Fig. 4) . The monoclonal Ab to IGF-I had no effect when added alone (Table I) . Insulin (plus 0.5% HPS) at 1,000 ng/ml (10-fold the IGF-I dose) increased TI by 528±57%. Neither the specific IGF-I monoclonal nor the unrelated heart worm Ab had any effect on insulin-stimulated DNA synthesis (Table I ). The fibroblast mitogen EGF was added at 10 ng/ml in the presence of 0.5% hypox serum. An increase in TI of 3,050±50% was seen (n = 2), with no blunting in the presence of the monoclonal Ab to IGF-I (1:1,000). The effect on TI of increasing concentrations of the monoclonal Ab to IGF-I was examined in the presence of hGH or IGF-I (plus 0.5% hypox serum), both at 10 ng/ml (Fig. 5) . TI induced by IGF-I and hGH was reduced by the Ab in a dosedependent and parallel fashion at concentrations of the Ab of 1:5,000, 1:1,000, and 1:500 (P < 0.01 for each).
To characterize the likely chronological relationship between growth hormone addition and resultant IGF-I-induced DNA synthesis, we compared the time course of TI stimulated either by IGF-I or hGH at 10 ng/ml (in the presence of 0.5% hypox serum) when added to the fibroblasts at regular intervals over a 28-h time course. Thymidine was added for the last 3 h as before. Fig. 6 shows the results of a representative of the three experiments performed in triplicate. The effect of hGH lagged behind that of IGF-I by 4-10 h, reaching a similar peak of 1,800 cpm at 28 h, compared with 22 h for IGF-I.
Cell replication experiments
As a specific index of mitogenesis we examined cell replication stimulated by hGH and IGF-I in four experiments as shown in Fig. 7 . 0.5% hypox serum alone, IGF alone, or hGH alone had no effect on cell replication compared with SEMI (data not shown). However, in the presence of 0.5% HPS, IGF-I at 10 ng/ml and hGH at 10 ng/ml gave a similar stimulation of cell replication with a mean increase over baseline cell counts for SFM of 169±22% and 172±12%, respectively. Addition of the monoclonal Ab to IGF-I reduced cell counts stimulated, respectively, by IGF-I and hGH to 42±8% and 32±5% of these values ( heart worm Ab to IGF-I and hGH had no effect on the stimulated cell counts. Neither heart worm Ab nor the monoclonal Ab to IGF-I had any effect on cell replication when added alone. Nor did they have any effect on cell replication stimulated by insulin at 1,000 ng/ml (Table I) .
Discussion
We have shown that hGH stimulates mitogenesis in human fibroblasts in the absence of exogeneous IGF-I, as shown by TI and cell replication studies. The action of hGH on DNA synthesis required competence factors present in HPS as has been previously described for IGF-I's mitogenic action (10, 19, 22) . Platelet-derived growth factor (PDGF) is such a competence factor recognized as being necessary for stimulation of human fibroblast growth by several hormones including IGF-I (11, 19) . Furthermore, PDGF, fibroblast growth factor, and macrophage growth factor can stimulate the production of somatomedin by cultured human fibroblasts (1 1). Consequently, the effects of PDGF on DNA synthesis in this system are blunted by IGF-I monoclonal Ab (23). It is thus possible that PDGF and other unidentified factors in the HPS were able to stimulate small quantities of local IGF-I secretion. This cannot be excluded, since our assay did not measure IGF-I in conditioned media. But, consequent effects on mitogenesis were minimal, as seen in Fig. 1 , suggesting that the primary role of HPS in our system was the provision of competence factors, allowing synergism with hGH or IGF-I. Culture density, cell passage number, the time since the last media change, and the duration of incubation are important variables controlling IGF-I production by cultured human fibroblasts (12) , and they were controlled as much as possible in our experiments. Nevertheless, significant quantitative variation in the GH effect was seen between sets of experiments, each of which was performed on a single cell line. As described previously for other biological effects, including insulin binding to human fibroblasts (24), it is likely that fibroblast cell lines differ in their GH responsiveness. This may represent variations in GH receptor status, or a postreceptor-regulated phenomenon. The effect of hGH was dose dependent, with half-maximal effect at 10 ng/ml or 0.5 nM, in the physiologic range and consistent with the affinity for the fibroblast hGH receptor (13) . In previous studies (22) , IGF-I has demonstrated a halfmaximal effect on DNA synthesis in human fibroblasts at a similar concentration (10 ng/ml or 1.3 nM). We therefore compared hGH with IGF-I at 10 ng/ml for each. In each of the studies described, hGH mimics the IGF-I effect at these doses, suggesting similar mechanisms, and further, suggesting molar equivalence. Whereas TI is widely accepted as an index of DNA synthesis, thymidine transport and thymidine kinase activity can be sensitive to the growth state of the cells, so that measuring TI into DNA may not always accurately reflect DNA synthesis (25) . We therefore examined cell replication as a specific index of mitogenesis to confirm our findings. To further study whether hGH was exerting its mitogenic action on human fibroblasts via local IGF-I production we made use of the monoclonal Ab to IGF-I. The addition of this Ab blunted TI and cell replication stimulated by both hGH and IGF-I to a similar degree. The lack of any blunting effect by the monoclonal heart worm Ab supported the specificity of the monoclonal Ab to IGF-I. Furthermore, whereas both hGHand IGF-I-stimulated DNA synthesis were blunted by the monoclonal Ab to IGF-I, neither insulin nor EGF-stimulated DNA synthesis were affected by the Ab. Insulin has previously been shown to mimic mitogenic effects of IGF-I at high concentrations (26 The time course over 28 h for TI stimulated by IGF-I and hGH showed a time lag for the GH-stimulated effects of 4-10 h. It is of interest to compare this in vitro time lag with the in vivo delay of 12 h that D'Ercole and co-workers noted between injecting GH and observing the maximal rise of IGF-I extractable from tissues in hypophysectomised rats (32) . The time lag noted in our studies, therefore, further supports the notion that the mitogenic effect of hGH in human fibroblasts is entirely mediated by IGF-I synthesized locally during the 4-10-h period. Further studies with cDNA probes for IGF-I will allow determination of the components of the time lag from hGH exposure to DNA transcription and protein synthesis. We were unable to measure IGF-I in the conditioned media aspirated at the time of the cell harvesting. (The lower sensitivity limit of the Immunonuclear Corp. kit used was 5 ng/ml). IGF-I has been measured frequently in the media of cultured human fibroblasts stimulated by a variety of hormones (9, 11, 12) . However, it was not detected in the media of cultured bovine chondrocytes where GH appeared to be stimulating growth via local IGF-I production by the chondrocytes (33) . It is possible that in some instances the locally produced IGF-I binds immediately to receptor sites so that the media concentration remains low, or that locally produced binding proteins (30, 31) interfere with measurement. However, our monoclonal Ab studies clearly indicate local production of IGF-I, to which the Ab binds. A recent study has characterized the somatomedin-IGF-I-like peptide secreted from human fibroblasts, showing it to be of higher molecular weight and biologically more potent than circulating IGF-I (34). However, it is functionally similar to IGF-I and binds to the IGF-I monoclonal Ab used in our studies (34) . Though we have not directly demonstrated secretion of a biologically active IGF under the influence of hGH, blunting of the GH-induced effects by this Ab indicates that GH-induced mitogenesis is at least in part mediated by local production of such a biologically active IGF-I-like peptide.
These studies of the relationship between hGH and its mitogenic response in human tissues further support a direct link to local tissue secretion and availability to IGF-I as the mediator of hGH action, or at least provide a necessary local component for maximal GH-induced mitogenesis. We have (i) provided further evidence for mitogenic effects of hGH in cultured skin fibroblasts, mimicking effects of IGF-I at similar half-maximal doses; (ii) demonstrated that hGH's mitogenic action on cultured human fibroblasts is mediated, at least in part, via local IGF-I production, as indicated by (a) blunting of hGH effects by a monoclonal Ab to IGF-I and (b) demonstration of a consistent time lag between hGH-induced and IGF-I-induced mitogenesis. Our findings are consistent with a GH-dependent paracrine-autocrine role for IGF-I, and the cell surface and intracellular events that occur require further investigation.
